229 related articles for article (PubMed ID: 29564657)
1. Gemcitabine-cisplatin (GC) as adjuvant chemotherapy in resected stage II and stage III gallbladder cancers (GBC): a potential way forward.
Ostwal V; Swami R; Patkar S; Majumdar S; Goel M; Mehta S; Engineer R; Mandavkar S; Kumar S; Ramaswamy A
Med Oncol; 2018 Mar; 35(4):57. PubMed ID: 29564657
[TBL] [Abstract][Full Text] [Related]
2. Neoadjuvant chemotherapy with gemcitabine plus cisplatin followed by radical liver resection versus immediate radical liver resection alone with or without adjuvant chemotherapy in incidentally detected gallbladder carcinoma after simple cholecystectomy or in front of radical resection of BTC (ICC/ECC) - a phase III study of the German registry of incidental gallbladder carcinoma platform (GR)- the AIO/ CALGP/ ACO- GAIN-trial.
Goetze TO; Bechstein WO; Bankstahl US; Keck T; Königsrainer A; Lang SA; Pauligk C; Piso P; Vogel A; Al-Batran SE
BMC Cancer; 2020 Feb; 20(1):122. PubMed ID: 32059704
[TBL] [Abstract][Full Text] [Related]
3. Gemcitabine-cisplatin versus gemcitabine-oxaliplatin doublet chemotherapy in advanced gallbladder cancers: a match pair analysis.
Ramaswamy A; Ostwal V; Pinninti R; Kannan S; Bhargava P; Nashikkar C; Mirani J; Banavali S
J Hepatobiliary Pancreat Sci; 2017 May; 24(5):262-267. PubMed ID: 28196310
[TBL] [Abstract][Full Text] [Related]
4. Gallbladder cancer (GBC): 10-year experience at Memorial Sloan-Kettering Cancer Centre (MSKCC).
Duffy A; Capanu M; Abou-Alfa GK; Huitzil D; Jarnagin W; Fong Y; D'Angelica M; Dematteo RP; Blumgart LH; O'Reilly EM
J Surg Oncol; 2008 Dec; 98(7):485-9. PubMed ID: 18802958
[TBL] [Abstract][Full Text] [Related]
5. [A Case of Surgical Resection for Gallbladder Cancer with Para-Aortic Lymph Node Metastasis Following Neoadjuvant Chemotherapy with Gemcitabine, Cisplatin, and TS-1].
Nagaoka S; Yamada D; Eguchi H; Noda T; Asaoka T; Wada H; Kawamoto K; Gotoh K; Umeshita K; Doki Y; Mori M
Gan To Kagaku Ryoho; 2016 Nov; 43(12):1600-1602. PubMed ID: 28133070
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic outcomes and prognostic factors in unresectable gallbladder cancer treated with gemcitabine plus cisplatin.
You MS; Ryu JK; Choi YH; Choi JH; Huh G; Paik WH; Lee SH; Kim YT
BMC Cancer; 2019 Jan; 19(1):10. PubMed ID: 30611225
[TBL] [Abstract][Full Text] [Related]
7. Effect of Adjuvant Gemcitabine Combined with Low-dose 5-Fluorouracil and Cisplatin Chemotherapy for Advanced Biliary Carcinoma.
Morine Y; Shimada M; Ikemoto T; Arakawa Y; Iwahashi S; Saito YU; Yamada S; Imura S
Anticancer Res; 2017 Nov; 37(11):6421-6428. PubMed ID: 29061828
[TBL] [Abstract][Full Text] [Related]
8. Prospective Randomized Controlled Trial Comparing Adjuvant Chemotherapy vs. No Chemotherapy for Patients with Carcinoma of Gallbladder Undergoing Curative Resection.
Saluja SS; Nekarakanti PK; Mishra PK; Srivastava A; Singh K
J Gastrointest Surg; 2022 Feb; 26(2):398-407. PubMed ID: 34545545
[TBL] [Abstract][Full Text] [Related]
9. Modified gemcitabine and oxaliplatin or gemcitabine + cisplatin in unresectable gallbladder cancer: Results of a phase III randomised controlled trial.
Sharma A; Kalyan Mohanti B; Pal Chaudhary S; Sreenivas V; Kumar Sahoo R; Kumar Shukla N; Thulkar S; Pal S; Deo SV; Pathy S; Ranjan Dash N; Kumar S; Bhatnagar S; Kumar R; Mishra S; Sahni P; Iyer VK; Raina V
Eur J Cancer; 2019 Dec; 123():162-170. PubMed ID: 31707181
[TBL] [Abstract][Full Text] [Related]
10. [Chemotherapy in gallbladder carcinoma].
Abahssain H; Afchain P; Melas N; Ismaili N; Rahali R; Rabti HM; Errihani H
Presse Med; 2010 Dec; 39(12):1238-45. PubMed ID: 21074352
[TBL] [Abstract][Full Text] [Related]
11. Gemcitabine-based adjuvant chemotherapy for patients with advanced gallbladder cancer.
Nakamura M; Nakashima H; Abe T; Ensako T; Yoshida K; Hino K
Anticancer Res; 2014 Jun; 34(6):3125-9. PubMed ID: 24922682
[TBL] [Abstract][Full Text] [Related]
12. Prospective multicenter phase II study of gemcitabine plus cisplatin in patients with unresectable gallbladder cancer.
Hirooka Y; Ishikawa T; Kawashima H; Ohno E; Nonogaki K; Kanamori A; Hirai T; Uchida H; Shirai O; Ishikawa H; Goto H
Cancer Chemother Pharmacol; 2017 Jul; 80(1):119-125. PubMed ID: 28536803
[TBL] [Abstract][Full Text] [Related]
13. Gemcitabine combined with cisplatin as adjuvant chemotherapy for non-small cell lung cancer: A retrospective analysis.
Ma D; Wang J; Hao X; Wang Y; Hu X; Xing P; Li J
Thorac Cancer; 2017 Sep; 8(5):482-488. PubMed ID: 28745824
[TBL] [Abstract][Full Text] [Related]
14. Adjuvant radio-chemotherapy after extended or simple cholecystectomy in gallbladder cancer.
González ME; Giannini OH; González P; Saldaña B
Clin Transl Oncol; 2011 Jul; 13(7):480-4. PubMed ID: 21775275
[TBL] [Abstract][Full Text] [Related]
15. Infusion chemotherapy with cisplatinum and fluorouracil in the treatment of locally-advanced and metastatic gallbladder cancer.
Chatni SS; Sainani RS; Mehta SA; Mohandas KM
J Cancer Res Ther; 2008; 4(4):151-5. PubMed ID: 19052386
[TBL] [Abstract][Full Text] [Related]
16. [Resection of Initially Unresectable Gallbladder Cancer with Multiple Liver Metastases after Chemotherapy with Gemcitabine plus Cisplatin].
Ajiki T; Matsumoto T; Shinozaki K; Murakami S; Kinoshita H; Goto T; Asari S; Toyama H; Kido M; Fukumoto T; Ku Y
Gan To Kagaku Ryoho; 2015 Nov; 42(12):1500-2. PubMed ID: 26805076
[TBL] [Abstract][Full Text] [Related]
17. Cisplatin plus gemcitabine as adjuvant chemotherapy for radically resected non-small-cell lung cancer: a pilot study.
Tibaldi C; Mazzoni E; Arcabasso G; D'Incecco A; Antonuzzo A; Menconi G; Falcone A
Clin Lung Cancer; 2009 Jan; 10(1):53-7. PubMed ID: 19289373
[TBL] [Abstract][Full Text] [Related]
18. Comparison between neoadjuvant and adjuvant gemcitabine plus cisplatin chemotherapy for muscle-invasive bladder cancer.
Matsubara N; Mukai H; Naito Y; Nezu M; Itoh K
Asia Pac J Clin Oncol; 2013 Dec; 9(4):310-7. PubMed ID: 23127231
[TBL] [Abstract][Full Text] [Related]
19. Randomized Phase III Trial of Dose-dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin, or Gemcitabine and Cisplatin as Perioperative Chemotherapy for Patients with Muscle-invasive Bladder Cancer. Analysis of the GETUG/AFU V05 VESPER Trial Secondary Endpoints: Chemotherapy Toxicity and Pathological Responses.
Pfister C; Gravis G; Fléchon A; Soulié M; Guy L; Laguerre B; Mottet N; Joly F; Allory Y; Harter V; Culine S;
Eur Urol; 2021 Feb; 79(2):214-221. PubMed ID: 32868138
[TBL] [Abstract][Full Text] [Related]
20. Adjuvant treatment of resectable biliary tract cancer with cisplatin plus gemcitabine: A prospective single center phase II study.
Siebenhüner AR; Seifert H; Bachmann H; Seifert B; Winder T; Feilchenfeldt J; Breitenstein S; Clavien PA; Stupp R; Knuth A; Pestalozzi B; Samaras P
BMC Cancer; 2018 Jan; 18(1):72. PubMed ID: 29325521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
